M A Gill

434 total citations
22 papers, 366 citations indexed

About

M A Gill is a scholar working on Pharmacology, Surgery and Emergency Medicine. According to data from OpenAlex, M A Gill has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Surgery and 7 papers in Emergency Medicine. Recurrent topics in M A Gill's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Gallbladder and Bile Duct Disorders (5 papers) and Appendicitis Diagnosis and Management (5 papers). M A Gill is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Gallbladder and Bile Duct Disorders (5 papers) and Appendicitis Diagnosis and Management (5 papers). M A Gill collaborates with scholars based in United States, United Kingdom and Canada. M A Gill's co-authors include Peter N.R. Heseltine, Maria D. Appleman, Albert E. Yellin, Thomas V. Berne, Kevin C. Chung, Yong Suk Moon, Jack W. Kern, Mark P. Okamoto, Robert A. Wise and J. M. Andrews and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and The Journal of Infectious Diseases.

In The Last Decade

M A Gill

19 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M A Gill United States 11 215 135 117 59 57 22 366
Rubén A. Giuliano Belgium 9 342 1.6× 106 0.8× 112 1.0× 33 0.6× 37 0.6× 12 488
Seth R. Bauer United States 12 186 0.9× 146 1.1× 195 1.7× 44 0.7× 58 1.0× 37 490
P. Cougot France 12 277 1.3× 159 1.2× 185 1.6× 37 0.6× 96 1.7× 22 428
Stephen H. Powell United States 6 190 0.9× 100 0.7× 157 1.3× 71 1.2× 16 0.3× 19 471
Kathryn J. Eagye United States 14 196 0.9× 189 1.4× 142 1.2× 25 0.4× 138 2.4× 25 452
Martin H. Adelman United States 12 115 0.5× 49 0.4× 95 0.8× 24 0.4× 99 1.7× 19 424
Fabio Taccone Belgium 10 242 1.1× 69 0.5× 178 1.5× 31 0.5× 58 1.0× 24 386
Donald S. North United States 12 229 1.1× 101 0.7× 209 1.8× 64 1.1× 26 0.5× 23 610
Paraskevi Tselioti Greece 7 163 0.8× 314 2.3× 187 1.6× 25 0.4× 116 2.0× 12 578
Bin Du China 11 84 0.4× 143 1.1× 196 1.7× 45 0.8× 69 1.2× 35 606

Countries citing papers authored by M A Gill

Since Specialization
Citations

This map shows the geographic impact of M A Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Gill more than expected).

Fields of papers citing papers by M A Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Gill. The network helps show where M A Gill may publish in the future.

Co-authorship network of co-authors of M A Gill

This figure shows the co-authorship network connecting the top 25 collaborators of M A Gill. A scholar is included among the top collaborators of M A Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Gill. M A Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gill, M A. (2025). Napoleon’s Playbook: The Political Strategies behind His Empire and Legacy. 15(1). 1–12. 1 indexed citations
2.
Gill, M A, et al.. (2023). CLOPIDOGREL INDUCED ISOLATED THROMBOCYTOPENIA. CHEST Journal. 164(4). A2049–A2050.
3.
Inagaki, Kazuhiro, et al.. (2015). Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated y-site administration.. PubMed. 2(4). 318–21.
4.
Baines, Paul & M A Gill. (2005). The Eu Constitution and the British Public: What the Polls Tell Us About the Campaign That Never Was. International Journal of Public Opinion Research. 18(4). 463–474. 3 indexed citations
5.
Moon, Yong Suk, Kevin C. Chung, & M A Gill. (1997). Pharmacokinetics of Meropenem in Animals, Healthy Volunteers, and Patients. Clinical Infectious Diseases. 24(Supplement 2). S249–S255. 59 indexed citations
6.
Yellin, Albert E., Thomas V. Berne, Maria D. Appleman, et al.. (1994). A randomized study of cefepime versus the combination of gentamicin and meziocillin as an adjunct to surgical treatment in patients with acute cholecystitis. International Journal of Gynecology & Obstetrics. 46(3). 352–352. 16 indexed citations
7.
Berne, Thomas V., Albert E. Yellin, Maria D. Appleman, Peter N.R. Heseltine, & M A Gill. (1994). A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis. International Journal of Gynecology & Obstetrics. 46(3). 352–352. 28 indexed citations
8.
Okamoto, Mark P., Peter N.R. Heseltine, Maria D. Appleman, et al.. (1994). Pharmacokinetics of meropenem in patients with intra-abdominal infections. Antimicrobial Agents and Chemotherapy. 38(1). 151–154. 59 indexed citations
9.
Jhee, Stanford S., et al.. (1994). Comparison of aminoglycoside pharmacokinetics in Asian, Hispanic, and Caucasian patients by using population pharmacokinetic methods. Antimicrobial Agents and Chemotherapy. 38(9). 2073–2077. 12 indexed citations
10.
Sirinek, Kenneth R., Philip R. Schauer, Albert E. Yellin, et al.. (1994). Single-dose cefuroxime versus multiple-dose cefazolin as prophylactic therapy for high-risk cholecystectomy.. PubMed. 178(4). 321–5. 3 indexed citations
11.
Sclar, David A., Tracy L. Skaer, Linda M. Robison, et al.. (1993). Effect of antihypertensive formulation on health service expenditures. Clinical Autonomic Research. 3(6). 363–368. 5 indexed citations
12.
Baldwin, David, Robert A. Wise, J. M. Andrews, M A Gill, & D. Honeybourne. (1993). Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration. Respiratory Medicine. 87(8). 595–601. 25 indexed citations
13.
Yellin, Albert E., Thomas V. Berne, Peter N.R. Heseltine, et al.. (1993). Prospective randomized study of two different doses of clindamycin admixed with gentamicin in the management of perforated appendicitis.. PubMed. 59(4). 248–55. 10 indexed citations
14.
Chin, Alfred, Mark P. Okamoto, M A Gill, et al.. (1990). Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue. Antimicrobial Agents and Chemotherapy. 34(12). 2354–2357. 7 indexed citations
15.
Chin, Alfred, M A Gill, Matthew K. Ito, et al.. (1990). Treatment of intra-abdominal infections: cost comparison of ampicillin/sulbactam and clindamycin/gentamicin.. PubMed. 25(3). 295–6, 303. 4 indexed citations
16.
Berne, Thomas V., et al.. (1990). Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy.. PubMed. 170(2). 137–40. 15 indexed citations
17.
Ito, Mamoru, M A Gill, Thomas V. Berne, et al.. (1988). Intraoperative serum, bile, and gallbladder-wall concentrations of cefmetazole in patients undergoing cholecystectomy.. PubMed. 7(6). 467–8. 2 indexed citations
18.
Gill, M A, et al.. (1988). Sulbactam: a beta-lactamase inhibitor.. PubMed. 7(1). 37–51. 41 indexed citations
19.
Heseltine, Peter N.R., Albert E. Yellin, Maria D. Appleman, et al.. (1983). Perforated and Gangrenous Appendicitis: An Analysis of Antibiotic Failures. The Journal of Infectious Diseases. 148(2). 322–329. 60 indexed citations
20.
Gill, M A, et al.. (1978). Phenytoin overdose. Kinetics.. PubMed. 128(3). 246–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026